SCHEMBL13799166

SCHEMBL13799166

Cc1cnc(-c2cccc(Br)c2)cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.49
METAP2 P50579 1/20 0.49
RAB9A P51151 4/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
HK1 P19367 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
NPC1 O15118 3/20 0.43
HCRTR1 O43613 1/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
GABRG2 P18507 5/20 0.42
GABRB3 P28472 5/20 0.42
GABRA5 P31644 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22618053 0.85 GABRA1 (0.46) IDO1METAP2RAB9AMAPTALDH1A1
SCHEMBL18540376 0.83 IDO1 (0.44) IDO1METAP2RAB9AMAPTALDH1A1
SCHEMBL13299575 0.81 IDO1 (0.51) IDO1METAP2RAB9ANPC1KDM4E
SCHEMBL17027901 0.81 IDO1 (0.58) IDO1METAP2RAB9AMAPTALDH1A1
SCHEMBL13834213 0.80 LDHA (0.51) IDO1RAB9AMAPTALDH1A1NPC1
SCHEMBL2481915 0.79 LDHA (0.62) IDO1RAB9AMAPTALDH1A1NPC1
SCHEMBL29507311 0.79 LDHA (0.62) IDO1RAB9AMAPTALDH1A1NPC1
SCHEMBL2482706 0.79 CYP3A4 (0.54) IDO1METAP2RAB9AMAPTALDH1A1
SCHEMBL22053018 0.79 IDO1 (0.49) IDO1METAP2RAB9AMAPTALDH1A1
SCHEMBL22183174 0.77 HSD17B1 (0.45) IDO1METAP2RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed
US-20220056063-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-02-24 US disclosed
US-11214587-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-01-04 US disclosed
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-05-09 US disclosed
US-20180097189-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-04-05 US disclosed
US-9899612-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-02-20 US disclosed
US-9899612-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-02-20 US disclosed
US-9865826-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-01-09 US disclosed
US-8778508-B2 Light-emitting organometallic complexes UNIVERSAL DISPLAY CORPORATION (US) 2014-07-15 US disclosed
US-8778508-B2 Light-emitting organometallic complexes UNIVERSAL DISPLAY CORPORATION (US) 2014-07-15 US disclosed
US-8519130-B2 Method for synthesis of iriduim (III) complexes with sterically demanding ligands UNIVERSAL DISPLAY CORPORATION (US) 2013-08-27 US disclosed
US-8519130-B2 Method for synthesis of iriduim (III) complexes with sterically demanding ligands UNIVERSAL DISPLAY CORPORATION (US) 2013-08-27 US disclosed
WO-2009073245-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2009-06-11 WO disclosed
WO-2009073246-A1 METHOD FOR THE SYNTHESIS OF IRIDIUM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION (US) 2009-06-11 WO disclosed
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION 2009-05-14 US disclosed
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS UNIVERSAL DISPLAY CORPORATION 2009-05-14 US disclosed
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION 2009-04-30 US disclosed
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES UNIVERSAL DISPLAY CORPORATION 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685756-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OPRD1 IDO1 92/4885METAP2 4369/4885RAB9A 1983/4885
US-20220056063-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OPRD1 IDO1 92/4885METAP2 4369/4885RAB9A 1983/4885
US-20180097189-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LEF1, CRY1, CYP1A1 IDO1 534/4885METAP2 2674/4885RAB9A 3260/4885
US-20090108737-A1 LIGHT-EMITTING ORGANOMETALLIC COMPLEXES CRY1, LAGE3, CRY2 IDO1 2368/4885METAP2 3089/4885RAB9A 2783/4885
US-11214587-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OPRD1 IDO1 92/4885METAP2 4369/4885RAB9A 1983/4885
US-20090124805-A1 METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS PAICS, ITPA, MPI IDO1 490/4885METAP2 4345/4885RAB9A 2095/4885
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OPRD1 IDO1 92/4885METAP2 4369/4885RAB9A 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.